Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Oncologist
; 2022 Apr 21.
Article
in En
| MEDLINE
| ID: mdl-35445723
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
United States